title: Use of xenogeneic islets in hybrid artificial pancreas for treatment of diabetes without immunosuppression.
authors.affiliation: Division of Organ Transplantation, New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts 02215.
authors.forename: H
authors.initials: H
authors.lastname: Ohzato
authors.forename: M
authors.initials: M
authors.lastname: Carretta
authors.forename: T
authors.initials: T
authors.lastname: Maki
authors.forename: S J
authors.initials: SJ
authors.lastname: Sullivan
authors.forename: K
authors.initials: K
authors.lastname: Borland
authors.forename: T E
authors.initials: TE
authors.lastname: Muller
authors.forename: B A
authors.initials: BA
authors.lastname: Solomon
authors.forename: W L
authors.initials: WL
authors.lastname: Chick
authors.forename: A P
authors.initials: AP
authors.lastname: Monaco
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D002417:Cattle; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000188:drug therapy / Q000601:surgery*; D004285:Dogs; D005260:Female; D007332:Insulin Infusion Systems; D049528:Insulin, Long-Acting / Q000627:therapeutic use; D016381:Islets of Langerhans Transplantation / Q000379:methods* / Q000502:physiology; D010180:Pancreatectomy; D014183:Transplantation, Heterologous / Q000379:methods / Q000502:physiology
chemical_list: D001786:Blood Glucose; D049528:Insulin, Long-Acting